|
Volumn 133, Issue 6, 2011, Pages 1611-1613
|
A myelin-specific contrast agent for magnetic resonance imaging of myelination
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL PROCESS;
BRAIN REGIONS;
CLINICAL OUTCOME;
CONTRAST AGENT;
DIRECT DETECTION;
HIGH SPECIFICITY;
MOUSE BRAIN;
MR CONTRAST AGENTS;
MULTIPLE SCLEROSIS;
MYELINATION;
SIGNAL INTENSITIES;
TISSUE INJURY;
TISSUE WATER CONTENT;
VERTEBRATE NERVOUS SYSTEM;
BRAIN;
GADOLINIUM;
NEURODEGENERATIVE DISEASES;
RESONANCE;
WATER CONTENT;
MAGNETIC RESONANCE IMAGING;
GADOLINIUM PENTETATE;
GADOTERATE MEGLUMINE;
MYELIN;
NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CEREBELLUM;
CORPUS CALLOSUM;
CORPUS STRIATUM;
DRUG PROTEIN BINDING;
IMMUNOHISTOCHEMISTRY;
LEUKODYSTROPHY;
MOUSE;
MULTIPLE SCLEROSIS;
MYELINATION;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
TISSUE INJURY;
TISSUE WATER;
WATER CONTENT;
ANIMALS;
BRAIN;
CELL MEMBRANE;
CONTRAST MEDIA;
DRUG DESIGN;
GADOLINIUM;
MAGNETIC RESONANCE IMAGING;
MICE;
MYELIN SHEATH;
|
EID: 79951525354
PISSN: 00027863
EISSN: 15205126
Source Type: Journal
DOI: 10.1021/ja1040896 Document Type: Article |
Times cited : (30)
|
References (16)
|